Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy

ISSN： 0012-186X

Source： Diabetologia, Vol.51, Iss.9, 2008-09, pp. : 1574-1580

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Anti-VEGF Drugs as Adjuvant Therapy in Diabetic Retinopathy Surgery

Current Diabetes Reviews, Vol. 7, Iss. 3, 2011-05 ,pp. : 176-184

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetic Retinopathy: Current and New Treatment Options

Current Diabetes Reviews, Vol. 8, Iss. 1, 2012-01 ,pp. : 32-41

Bentham Science Publishers

Access to resources Recommend Favorite

Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy

By García-Ramírez M. Canals F. Hernández C. Colomé N. Ferrer C. Carrasco E. García-Arumí J. Simó R.

Diabetologia, Vol. 50, Iss. 6, 2007-06 ,pp. : 1294-1303

Springer Publishing Company

Access to resources Recommend Favorite

Anti-VEGF Anticancer Drugs: Mind the Hypertension

Recent Patents on Cardiovascular Drug Discovery, Vol. 9, Iss. 2, 2014-12 ,pp. : 63-72

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetic Retinopathy: Recent Updates on Different Biomarkers and Some Therapeutic Agents

Current Diabetes Reviews, Vol. 14, Iss. 6, 2018-12 ,pp. : 523-533

Bentham Science Publishers

Access to resources Recommend Favorite